Expert Consensus on Coriolus versicolor Vaginal Gel for HPV-Positive Women with Low-Grade Cervical Lesions
A multidisciplinary expert panel reached formal consensus that a Coriolus versicolor-based vaginal gel may increase lesion regression and viral clearance in HPV-positive women with low-grade cervical lesions.
| Population | — |
|---|---|
| Intervention | — |
| Comparator | — |
| Outcome | — |
What the study showed
All submitted statements achieved agreement levels above 80%. The abstract reports that the product demonstrated increased lesion regression and viral clearance rates, with potentially more pronounced benefits in women over 40 years of age. Limited additional studies are referenced but not detailed in the abstract.
How it was done
A rapid systematic review following PRISMA guidelines was conducted, with evidence levels assessed using SIGN criteria. A multidisciplinary expert panel then formulated and voted on consensus statements using the nominal group technique.
Risk of bias
This is an expert consensus based on a rapid systematic review, not a primary clinical trial. The abstract does not specify the number of included studies, pooled sample sizes, or panelists' conflict-of-interest profiles, limiting independent critical appraisal.
What this study does NOT prove
This consensus does not prove causal efficacy of Coriolus versicolor gel in preventing progression to high-grade cervical intraepithelial neoplasia or cervical cancer.
In clinical practice
This document may inform clinical discussions but does not replace evidence from adequately controlled randomized trials. Clinical adoption should remain cautious until RCTs with validated endpoints are available.
Limitations
This is an expert consensus based on a rapid systematic review, not a primary clinical trial. The abstract does not specify the number of included studies, pooled sample sizes, or panelists' conflict-of-interest profiles, limiting independent critical appraisal.
Technical appendix
Version history
- 1.0 · 2026-07-30 — Auto-generated under Evidence Standard v1.0
Paid access: structured summary from public metadata; consult the original study at the source.